• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Binimetinib CAS 606143-89-9 Raw Materials Powder

    • Binimetinib CAS 606143-89-9 Raw Materials Powder
    • Binimetinib CAS 606143-89-9 Raw Materials Powder
    • Binimetinib CAS 606143-89-9 Raw Materials Powder storehouse
    • Binimetinib CAS 606143-89-9 Raw Materials Powder quality testing
    • Binimetinib CAS 606143-89-9 Raw Materials Powder quality testing
    • Binimetinib CAS 606143-89-9 Raw Materials Powder certificate

    Product Overview:

    Binimetinib Powder is an oral antitumor drug used to treat malignancies such as lung, colon, stomach, and pancreatic cancers. It is a tyrosine kinase inhibitor that can inhibit the growth and division of tumor cells, thus achieving the effect of tumor treatment.
    Binimetinib CAS 606143-89-9 is a reversible inhibitor of mitogen activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 activity. MEK proteins are upstream regulators of the extracellular signal-associated kinase (ERK) pathway. In vitro, Binimetinib Raw Materials inhibited the phosphating of ERK in a cell-free trial and inhibited BRAF mutinous melanoma cells. Binimetinib is a kinase inhibitor for patients with melanoma, a type of skin cancer.

    Binimetinib CAS 606143-89-9 Raw Materials Powder Attributes

    Name: Binimetinib CAS 606143-89-9 Raw Materials Powder

    CAS: 606143-89-9

    MF: C17H15BrF2N4O3

    Binimetinib

    MW: 441.23

    Specification​: 99% min Binimetinib 

    Sample: Binimetinib Powder

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https://henrikang.en.made-in-china.com/

    Binimetinib CAS 606143-89-9 Raw Materials Powder Details

    Binimetinib Powder  Usage and Synthesis.

    Binimetinib Powder is an oral antitumor drug used to treat malignancies such as lung, colon, stomach, and pancreatic cancers. It is a tyrosine kinase inhibitor that can inhibit the growth and division of tumor cells, thus achieving the effect of tumor treatment.

    Binimetinib CAS 606143-89-9 is a reversible inhibitor of mitogen activated extracellular signal-regulated kinase 1 (MEK1) and MEK2 activity. MEK proteins are upstream regulators of the extracellular signal-associated kinase (ERK) pathway. In vitro, Binimetinib Raw Materials inhibited the phosphating of ERK in a cell-free trial and inhibited BRAF mutinous melanoma cells. Binimetinib is a kinase inhibitor for patients with melanoma, a type of skin cancer.

    Binimetinib Powder

    Binimetinib (MEK162), an oral MEK1 and MEK2 inhibitor, showed an objective remission rate of 10% in patients with NRAS mutations and 5% in patients with BRAF mutations in a phase II clinical study with 71 melanoma patients (30 with NRAS mutations and 41 with BRAF mutations) enrolled in a phase II study in which all enrolled patients were treated with Binimetinib 45 mg/dose twice daily.

    Application/Function of Binimetinib Powder.

    The main advantage of bemetinib is that it is more effective than pemetinib. Studies have shown that bemetinib can significantly reduce the growth and spread of cancer cells. In addition, bemetinib can significantly reduce chemotherapy drug toxicity and side effects in cancer patients.

    Binimetinib Powder

    By nature, bemetinib is a synthetic, non-natural antibiotic with antibacterial effects. Bemetinib, on the other hand, is a natural penicillin-based drug. The mechanism of action of these two drugs is not identical. In addition, the side effects of pemetinib and bemetinib are different.

    When choosing between pimertinib or bemetinib, it is important to consider the different properties of the two. Bimetinib is more antibacterial, while bemetinib has a stronger antiviral effect. In addition, bimetinib can help treat chronic sinusitis and asthma, while bemetinib is more effective in treating allergic sinusitis and asthma. Depending on the patient's specific situation, the doctor may recommend either bimetinib or bemetinib.

    Binimetinib Powder

    Bimetinib and bemetinib have received a lot of attention as the newest pair of anti-cancer drugs. These two drugs have great advantages and can effectively treat cancer. It is hoped that through their widespread use, they can effectively treat cancer and improve people's quality of life.

    Pharmacological effects of Binimetinib Powder

    Binimetinib (MEK162, ARRY-162, ARRY-438162) is a potent MEK1/2 inhibitor with an IC50 of 12 nM in a cell-free assay.Binimetinib induces G1 cell cycle arrest and apoptosis and induces autophagy in human NSCLC cell lines.Phase 3.

    Binimetinib Powder

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,